Total submissions: 28
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000075554 | SCV000106550 | no known pathogenicity | Lynch syndrome | 2013-09-05 | reviewed by expert panel | research | Multifactorial likelihood analysis posterior probability <0.001 |
Eurofins Ntd Llc |
RCV000121366 | SCV000110265 | likely benign | not specified | 2013-01-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000121366 | SCV000149381 | benign | not specified | 2017-07-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001082159 | SCV000153862 | benign | Hereditary nonpolyposis colorectal neoplasms | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000115472 | SCV000184334 | benign | Hereditary cancer-predisposing syndrome | 2014-08-29 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Department of Pathology and Laboratory Medicine, |
RCV000121366 | SCV000592441 | benign | not specified | 2016-08-12 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000115472 | SCV000684801 | benign | Hereditary cancer-predisposing syndrome | 2014-12-11 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000600229 | SCV000744683 | benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000034545 | SCV000805965 | likely benign | not provided | 2017-10-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000034545 | SCV000892682 | benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | MLH1: BS3:Supporting, BS1, BS2 |
Mendelics | RCV000600229 | SCV001136438 | likely benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000600229 | SCV001307916 | benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2019-02-11 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
ARUP Laboratories, |
RCV000121366 | SCV001433782 | benign | not specified | 2017-07-03 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001798063 | SCV002042075 | likely benign | Breast and/or ovarian cancer | 2022-12-16 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000121366 | SCV002071029 | benign | not specified | 2018-07-18 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000115472 | SCV002528720 | benign | Hereditary cancer-predisposing syndrome | 2020-07-02 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000121366 | SCV002550510 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Institute for Biomarker Research, |
RCV000115472 | SCV004014969 | benign | Hereditary cancer-predisposing syndrome | 2023-01-24 | criteria provided, single submitter | clinical testing | |
Biesecker Lab/Clinical Genomics Section, |
RCV000600229 | SCV000043330 | benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2023-10-03 | no assertion criteria provided | research | BA1 based on allele frequency in NFE of 0.00203 in gnomAD. |
ITMI | RCV000121366 | SCV000085548 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Mayo Clinic Laboratories, |
RCV000121366 | SCV000691867 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000600229 | SCV000734273 | likely benign | Colorectal cancer, hereditary nonpolyposis, type 2 | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000600229 | SCV000745682 | benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2016-10-21 | no assertion criteria provided | clinical testing | |
Center of Medical Genetics and Primary Health Care | RCV001269371 | SCV001448727 | benign | Malignant tumor of breast | no assertion criteria provided | clinical testing | ||
Clinical Genetics Laboratory, |
RCV000121366 | SCV001906126 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000034545 | SCV001921662 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000121366 | SCV001959081 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000121366 | SCV002036458 | benign | not specified | no assertion criteria provided | clinical testing |